When examining patients with early stage hormone receptor-positive breast cancer, serum apelin levels and the BMI were higher in patients with breast cancer compared to the age and BMI-matched healthy control group (p = 0.0001) [26]. This evidence concerns the gene APLN and breast carcinoma.